biguanides has been researched along with Heart Disease, Ischemic in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Margolis, DJ | 1 |
| Hoffstad, O | 1 |
| Strom, BL | 1 |
| Monami, M | 1 |
| Marchionni, N | 1 |
| Masotti, G | 1 |
| Mannucci, E | 1 |
2 other studies available for biguanides and Heart Disease, Ischemic
| Article | Year |
|---|---|
Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
Topics: Adult; Aged; Biguanides; Cohort Studies; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Ins | 2008 |
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease.
Topics: Aged; Biguanides; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Foll | 2008 |